Tag Archives: Academic–industry partnership to accelerate rational design of molecular glue degrader drugs for cancer treatment

Collaboration between ICR and NEOsphere set to transform cancer research with next-generation molecular glue technologies

(IN BRIEF) The Institute of Cancer Research and NEOsphere Biotechnologies have announced a new collaboration to accelerate the discovery of molecular glue degrader drugs, an innovative approach in targeted cancer therapy. The partnership will integrate ICR’s proprietary molecular glue library … Read the full press release